Prot #AFT-47: ARACOG: A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamide

Project: Research project

Project Details

StatusActive
Effective start/end date4/14/21 → 4/14/25

Funding

  • Alliance Foundation Trials, LLC ((OE) Prot #AFT-47 // (OE) Prot #AFT-47)
  • Bayer Consumer Care AG ((OE) Prot #AFT-47 // (OE) Prot #AFT-47)